Erişim şekli için "info:eu-repo/semantics/openAccess" Diğer Yayınlar Koleksiyonu listeleme
Toplam kayıt 7, listelenen: 1-7
-
Advances in quantitative analysis of astrocytes using machine learning
(Wolters Kluwer Medknow Publications, 2023)Astrocytes, a subtype of glial cells, are starshaped cells that are involved in the homeostasis and blood flow control of the central nervous system (CNS). They are known to provide structural and functional support to ... -
Prediction and targeting of interaction interfaces in g-rotein coupled receptor oligomers
(Bentham Science Publishers Ltd, 2018)Background: Communication within a protein complex is mediated by physical interactions made among the protomers. Evidence for both the allosteric regulation present among the protomers of the protein oligomer and of the ... -
A review of computational drug repositioning: Strategies, approaches, opportunities, challenges, and directions
(BMC, 2020)Drug repositioning is the process of identifying novel therapeutic potentials for existing drugs and discovering therapies for untreated diseases. Drug repositioning, therefore, plays an important role in optimizing the ... -
A survey of artificial intelligence/machine learning-based trends for prostate cancer analysis
(2024)Different types of cancer are more commonly encountered recently. This may be attributed to a variety of reasons, including heredity, changes in the living conditions (food, drinks, pollution, etc.), advancement in technology ... -
A survey of machine learning-based methods for COVID-19 medical image analysis
(Springer Science and Business Media Deutschland GmbH, 2023)The ongoing COVID-19 pandemic caused by the SARS-CoV-2 virus has already resulted in 6.6 million deaths with more than 637 million people infected after only 30 months since the first occurrences of the disease in December ... -
Utilization of biased G protein-coupled receptor signaling towards development of safer and personalized therapeutics
(MDPI, 2019)G protein-coupled receptors (GPCRs) are involved in a wide variety of physiological processes. Therefore, approximately 40% of currently prescribed drugs have targeted this receptor family. Discovery of beta-arrestin ...